Medical Marketing and Media Physicians will be more apt to choose high doses of simvastatin , atorvastatin and Crestor—for patients who can tolerate it—since those drugs have demonstrated that they improve health outcomes and prevent cardiovascular risks in trials. Sales ...
Clinical Advisor ... no preceding history of rash. Medical history was notable for rheumatoid arthritis, hypertension, and hyperlipidemia. The man's current medications included minocycline, metoprolol (Lopressor, Toprol), simvastatin (Zocor), and aspirin. No history ... and more »
U.S. News & World Report While Zetia does lower "bad" LDL cholesterol linked with heart attacks and strokes, it is no more effective than drugs such as Lipitor, Crestor, or simvastatin , according to Forbes.com. Unlike those other medicines, there is no evidence that Zetia ...
Family Practice News Digital Network Since the results of the ENHANCE (Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression) study were released in 2008, the value of adding ezetimibe has been questioned. In that controversial study, the combination of ...
Healio Shobana Ganesan, MD, Ito and colleagues studied the effects of simvastatin (Zocor, Merck), pravastatin (Pravachol, Bristol-Myers Squibb) and ezetimibe (Zetia, Merck) on GLUT4 in 3T3-L1 adipocytes that were differentiated using a hormonal cocktail for 3 ...
PharmaTimes The agency has approved Liptruzet (ezetimibe and atorvastatin ) tablets for the treatment of elevated low-density lipoprotein (LDL) cholesterol in patients with primary or mixed hyperlipidaemia as adjunctive therapy to diet. Taken once-daily, Merck says ...
Medscape Dallas, Texas— The US Food and Drug Administration (FDA) has approved a new lipid-lowering combination tablet that includes atorvastatin , which went off patent in 2011, and ezetimibe (Zetia, Merck/Schering-Plough. The combination, known as Liptruzet, ...
